Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expectations backed by robust subscriptions and profitability, while Wakefit’s muted GMP reflects cautious sentiment towards consumer-facing growth businesses, highlighting current investor preference for earnings visibility and consistency.
GIFT Nifty hits record open interest of $21.56 billion; contracts touch all-time high
GIFT Nifty has hit a record open interest of $21.56 billion, reflecting rising global investor participation in India’s offshore derivatives market. The milestone, achieved on